Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
2h
Zacks Investment Research on MSNWall Street Analysts Predict a 44.2% Upside in Novo Nordisk (NVO): Here's What You Should KnowShares of Novo Nordisk (NVO) have gained 2.9% over the past four weeks to close the last trading session at $80.15, but there could still be a solid upside left in the stock if short-term price ...
San Francisco, California-- (Newsfile Corp. - March 17, 2025) - Novo Nordisk A/S (NYSE: NVO) is facing a class-action lawsuit from investors who allege the pharmaceutical giant misled them about the ...
1d
Zacks.com on MSNNVO vs. LLY: Which Stock Is the Better Value Option?But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. We have found that the best way to discover great value opportunities is to pair a ...
4d
Zacks Investment Research on MSNNVO Stock Slips 4% as Roche Inks Obesity Drug Deal With ZealandNovo Nordisk’s NVO stock declined 4.3% on Wednesday after Roche RHHBY announced a license and collaboration deal worth $5.3 ...
NEW YORK, NY / ACCESS Newswire / March 14, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
Novo Nordisk A/S (NYSE: NVO) is facing a class-action lawsuit from investors who allege the pharmaceutical giant misled them about the prospects ...
Novo Nordisk (NVO) stock rebounds after Kepler Cheuvreux upgrades to Buy following a 42% stock drop over the past year. Read ...
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
Novo Nordisk ( NVO) stock was down more than 8% Monday morning after the Danish drugmaker shared new data on its ...
Viking Therapeutics remains speculative despite progress in its clinical portfolio, notably the VK2735 program for obesity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results